Advanced Biomed Inc.

US$1.98As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ADVBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (79.49%)
Diagnostics & Research
Beta (5Y) —
PE TTM 0.371
TSR TTM (79.40%)
Mkt cap US$3.271M
ROIC (46.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.21
11.39%
(33.70%)
Sell 3|10|10|12|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.04
0.04
0.04
0.04
4.67%
0.42%
9.71%
9.73%
Revenue$M
0.185
0.182
0.191
0.188
3.77%
2.94%
5.91%
1.54%
Peers (US$3.271M)
Cap (US$)
PE
18.88M
80.28x
Capital
TTM
5Y
10Y
Leveragex
0.490
0.149
0.129
EBIT/Intx
0.092
0.075
0.076
Own earn%
(12.46)
68.32
30.39
Sh yield%
54.01
36.38
41.53
Owners
Insiders/Inst%
11.56
26.27
Short interest%
1.98
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
27–33
$1 testx
—
Incr. ROIC%
3